Global Non-Opioid Pain Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Non-Opioid Pain Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.
Non-Opioid Pain Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-Opioid Pain Treatment market is projected to reach US$ 56280 million in 2034, increasing from US$ 19550 million in 2022, with the CAGR of 16.0% during the period of 2024 to 2034. Demand from Orthopaedic and Musculoskeletal Pain and Neuropathic Pain are the major drivers for the industry.
With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for Non-Opioid has increased significantly.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-Opioid Pain Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC
Segment by Type
Medical Cannabis Treatment
Capsaicin-derived Treatment
Menthol-containing Treatment
Omega 3 fatty acid-containing Treatment
Botulinum Toxins
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Non-Opioid Pain Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Non-Opioid Pain Treatment introduction, etc. Non-Opioid Pain Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Non-Opioid Pain Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Non-Opioid Pain Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-Opioid Pain Treatment market is projected to reach US$ 56280 million in 2034, increasing from US$ 19550 million in 2022, with the CAGR of 16.0% during the period of 2024 to 2034. Demand from Orthopaedic and Musculoskeletal Pain and Neuropathic Pain are the major drivers for the industry.
With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for Non-Opioid has increased significantly.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-Opioid Pain Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC
Segment by Type
Medical Cannabis Treatment
Capsaicin-derived Treatment
Menthol-containing Treatment
Omega 3 fatty acid-containing Treatment
Botulinum Toxins
Segment by Application
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Non-Opioid Pain Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Non-Opioid Pain Treatment introduction, etc. Non-Opioid Pain Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Non-Opioid Pain Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices